145 related articles for article (PubMed ID: 38377326)
1. Celebrating the Data from 100,000 Real-World Users of the MiniMed™ 780G System in Europe, Middle East, and Africa Collected Over 3 Years: From Data to Clinical Evidence.
Choudhary P; Arrieta A; van den Heuvel T; Castañeda J; Smaniotto V; Cohen O
Diabetes Technol Ther; 2024 Mar; 26(S3):32-37. PubMed ID: 38377326
[No Abstract] [Full Text] [Related]
2. Real-World Performance of the MiniMed™ 780G System: First Report of Outcomes from 4120 Users.
Silva JD; Lepore G; Battelino T; Arrieta A; Castañeda J; Grossman B; Shin J; Cohen O
Diabetes Technol Ther; 2022 Feb; 24(2):113-119. PubMed ID: 34524003
[No Abstract] [Full Text] [Related]
3. Early Real-World Performance of the MiniMed™ 780G Advanced Hybrid Closed-Loop System and Recommended Settings Use in the United States.
Thrasher JR; Arrieta A; Niu F; Cameron KR; Cordero TL; Shin J; Rhinehart AS; Vigersky RA
Diabetes Technol Ther; 2024 Mar; 26(S3):24-31. PubMed ID: 38377317
[No Abstract] [Full Text] [Related]
4. Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 Sensor.
Cordero TL; Dai Z; Arrieta A; Niu F; Vella M; Shin J; Rhinehart AS; McVean J; Lee SW; Slover RH; Forlenza GP; Shulman DI; Pop-Busui R; Thrasher JR; Kipnes MS; Christiansen MP; Buckingham BA; Pihoker C; Sherr JL; Kaiserman KB; Vigersky RA
Diabetes Technol Ther; 2023 Sep; 25(9):652-658. PubMed ID: 37252734
[No Abstract] [Full Text] [Related]
5. Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: Evidence from 12 870 real-world users.
Arrieta A; Battelino T; Scaramuzza AE; Da Silva J; Castañeda J; Cordero TL; Shin J; Cohen O
Diabetes Obes Metab; 2022 Jul; 24(7):1370-1379. PubMed ID: 35403792
[TBL] [Abstract][Full Text] [Related]
6. Real-world performance of the MiniMed 780G advanced hybrid closed loop system in Latin America: Substantial improvement in glycaemic control with each technology iteration of the MiniMed automated insulin delivery system.
Grassi B; Gómez AM; Calliari LE; Franco D; Raggio M; Riera F; Castro M; McVean J; van den Heuvel T; Arrieta A; Castañeda J; Cohen O
Diabetes Obes Metab; 2023 Jun; 25(6):1688-1697. PubMed ID: 36789699
[TBL] [Abstract][Full Text] [Related]
7. MiniMed 780G Six-Month Use in Children and Adolescents with Type 1 Diabetes: Clinical Targets and Predictors of Optimal Glucose Control.
Lombardo F; Passanisi S; Alibrandi A; Bombaci B; Bonfanti R; Delvecchio M; Di Candia F; Mozzillo E; Piccinno E; Piona CA; Rigamonti A; Scialabba F; Maffeis C; Salzano G
Diabetes Technol Ther; 2023 Jun; 25(6):404-413. PubMed ID: 36763343
[No Abstract] [Full Text] [Related]
8. Predictors of time in target glucose range in real-world users of the MiniMed 780G system.
Castañeda J; Mathieu C; Aanstoot HJ; Arrieta A; Da Silva J; Shin J; Cohen O
Diabetes Obes Metab; 2022 Nov; 24(11):2212-2221. PubMed ID: 35791621
[TBL] [Abstract][Full Text] [Related]
9. Real-world performance of the MiniMed™ 670G system in Europe.
Da Silva J; Bosi E; Jendle J; Arrieta A; Castaneda J; Grossman B; Cordero TL; Shin J; Cohen O
Diabetes Obes Metab; 2021 Aug; 23(8):1942-1949. PubMed ID: 33961340
[TBL] [Abstract][Full Text] [Related]
10. Advances in Automated Insulin Delivery with the Medtronic 780G: The Australian Experience.
Halim B; Abraham MB; Manos G; Arrieta A; Dai Z; Vogrin S; Lu J; MacIsaac R; Ekinci EI; Davis EA; Jenkins A; Shin J; Vigersky RA; Jones TW; O'Neal D
Diabetes Technol Ther; 2024 Mar; 26(3):190-197. PubMed ID: 38444313
[No Abstract] [Full Text] [Related]
11. Glycemic Outcomes During Real-World Hybrid Closed-Loop System Use by Individuals With Type 1 Diabetes in the United States.
Arunachalum S; Velado K; Vigersky RA; Cordero TL
J Diabetes Sci Technol; 2023 Jul; 17(4):951-958. PubMed ID: 35414272
[TBL] [Abstract][Full Text] [Related]
12. A Peek Under the Hood: Explaining the MiniMed™ 780G Algorithm with Meal Detection Technology.
Grosman B; Roy A; Lintereur L; Turksoy K; Benedetti A; Cordero TL; Vigersky RA; McVean J; Rhinehart AS; Cohen O
Diabetes Technol Ther; 2024 Mar; 26(S3):17-23. PubMed ID: 38377324
[TBL] [Abstract][Full Text] [Related]
13. Real-World User and Clinician Perspective and Experience with MiniMed™ 780G Advanced Hybrid Closed Loop System.
Kesavadev J; Basanth A; Krishnan G; Shankar A; Sanal G; Jothydev S
Diabetes Ther; 2023 Aug; 14(8):1319-1330. PubMed ID: 37278948
[TBL] [Abstract][Full Text] [Related]
14. Twelve-Month Follow-up from a Randomized Controlled Trial of Simplified Meal Announcement Versus Precise Carbohydrate Counting in Adolescents with Type 1 Diabetes Using the MiniMed™ 780G Advanced Hybrid Closed-Loop System.
Petrovski G; Campbell J; Pasha M; Hussain K; Khalifa A; Umer F; Almajaly D; Hamdar M; Heuvel TVD; Edd SN
Diabetes Technol Ther; 2024 Mar; 26(S3):76-83. PubMed ID: 38377327
[No Abstract] [Full Text] [Related]
15. Beneficial effects of automated insulin delivery over one-year follow-up in real life for youths and adults with type 1 diabetes irrespective of patient characteristics.
Henry Z; Villar Fimbel S; Bendelac N; Perge K; Thivolet C
Diabetes Obes Metab; 2024 Feb; 26(2):557-566. PubMed ID: 37905353
[TBL] [Abstract][Full Text] [Related]
16. Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control.
Lepore G; Rossini A; Bellante R; Corsi A; Scaranna C; Dodesini AR; Trevisan R
Acta Diabetol; 2022 Oct; 59(10):1309-1315. PubMed ID: 35857108
[TBL] [Abstract][Full Text] [Related]
17. Reducing Diabetes Burden in Medtronic's Automated Insulin Delivery Systems.
Forlenza GP; Dai Z; Niu F; Shin JJ
Diabetes Technol Ther; 2024 Mar; 26(S3):7-16. PubMed ID: 38377321
[No Abstract] [Full Text] [Related]
18. Glycemic control during Ramadan fasting in adolescents and young adults with type 1 diabetes on MiniMed™ 780G advanced hybrid closed‑loop system: A randomized controlled trial.
Elbarbary NS; Ismail EAR
Diabetes Res Clin Pract; 2022 Sep; 191():110045. PubMed ID: 35987309
[TBL] [Abstract][Full Text] [Related]
19. The MiniMed 780G automated insulin delivery system adapts to substantial changes in daily routine: Lessons from real world users during Ramadan.
Al-Sofiani ME; Petrovski G; Al Shaikh A; Alguwaihes A; Al Harbi M; Al Mohannadi D; Adjene A; Alagha A; Al Remeithi S; Alamuddin N; Arrieta A; Castañeda J; Chaar W; van den Heuvel T; Cohen O
Diabetes Obes Metab; 2024 Mar; 26(3):937-949. PubMed ID: 38151748
[TBL] [Abstract][Full Text] [Related]
20. MiniMed
McVean J; Miller J
Expert Rev Med Devices; 2021 Jun; 18(6):499-504. PubMed ID: 34014794
[No Abstract] [Full Text] [Related]
[Next] [New Search]
